written on 20.06.2014

AbbVie admits $46bn attempt to acquire Shire


Chicago-based AbbVie said long after the US stock market closed on 19 June that its first cash and stock-based offer to buy Shire in early May valued the company at £39.50 per share. The obvious reason for AbbVie's interest in Shire is the…